Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
4
×
fda
4
×
life sciences
national blog main
boston
clinical trials
san diego blog main
startups
deals
drug delivery
indiana blog main
investing
ipo
medical device
new york blog main
raleigh-durham blog main
san diego top stories
san francisco blog main
seattle blog main
vc
venture capital
480 biomedical
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
arrowmark partners
arsenal medical
asklepios biopharmaceutical
beta bionics
bigfoot biomedical
bioeurope
biogen
biomarin pharmaceutical
biotech ipos
bob langer
boston university
boulder/denver blog main
What
developing
4
×
ipo
million
company
medicines
new
raised
tests
therapeutics
activity
approvals
beta
bio
biogen
bionics
biotech
blood
brings
clamped
closed
covid
debut
delays
device
diabetes
disorders
driven
drug
dyne
dyne’s
economic
fast
fda
genetic
heads
including
isn’t
key
late
levels
Language
unset
Current search:
developing
×
fda
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests